Patient Guide: Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 44 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06036836
Status: ACTIVE_NOT_RECRUITING
Condition: Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 44 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • New Haven, Connecticut
  • Boston, Massachusetts
  • New Brunswick, New Jersey
  • • And 41 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily